Related Experiment Video
Updated: May 31, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
[Advances in injection of botulinum toxin in dysphagia and associated diseases]
1Department of Otolaryngology Head and Neck Surgery,the Sixth Medical Center of Chinese PLA General Hospital,Beijing,100048,China.
Abstract:
Dysphagia is a prevalent complication associated with a spectrum of neurological disorders and head and neck pathologies, profoundly compromising patients' quality of life. Botulinum toxin(BTX), through its inhibition of acetylcholine release at the neuromuscular junction, precisely attenuates the tonicity of the upper esophageal sphincter(UES), thereby emerging as a pivotal minimally invasive intervention for dysphagia. This article offers a comprehensive review of BTX applications in the management of dysphagia and related conditions, covering injection techniques, therapeutic efficacy, and safety profiles, with the aim of providing evidence-based guidance for clinical practice.
More Related Videos
05:50Subcutaneous Neurotrophin 4 Infusion Using Osmotic Pumps or Direct Muscular Injection Enhances Aging Rat Laryngeal Muscles
Published on: June 13, 2017
08:32Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
Related Concept Videos
Botulism
Skeletal Muscle Relaxants: Therapeutic Uses
Esophageal Achalasia
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...